Hudson Bay Capital Management LP Regulus Therapeutics Inc. Transaction History
Hudson Bay Capital Management LP
- $18.6 Billion
- Q2 2024
A detailed history of Hudson Bay Capital Management LP transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 249,940 shares of RGLS stock, worth $372,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
249,940
Previous 625,000
60.01%
Holding current value
$372,410
Previous $1.8 Million
75.17%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RGLS
# of Institutions
69Shares Held
53MCall Options Held
155KPut Options Held
34.2K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$19.2 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.25MShares$9.31 Million0.17% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$7.45 Million1.32% of portfolio
-
Octagon Capital Advisors LP New York, NY4.26MShares$6.35 Million1.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.05MShares$6.04 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $21.8M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...